John Schilling is a Partner, leads the Operations team for TPG Capital in the U.S. and E.U., and co-leads the healthcare team. Prior to joining TPG in 2011, John managed Sales and Marketing for the U.S. pharmaceutical business at Abbott and was a Partner at McKinsey & Company. John received his undergraduate degree in Biomedical Engineering from Duke, a Master’s in Biomedical Engineering from Johns Hopkins where he was a Bozzelli Scholar, and an M.D. from the University of Chicago where he received the Joseph A. Capps Award for the most outstanding student in clinical medicine. Thereafter, John conducted his residency training in surgery at Johns Hopkins. While at TPG, John has played leadership roles on TPG’s investments in Adare Pharmaceuticals, Aptalis, Beaver Visitec International, EnvisionRx, Immucor, and Par Pharmaceutical.